100 results
DEFA14A
CKPT
Checkpoint Therapeutics Inc
2 Apr 24
Additional proxy soliciting materials
6:03am
Additional Materials
¨ Soliciting Material under §240.14a-12
Checkpoint Therapeutics, Inc.
(Name of Registrant as Specified in its Charter)
(Name … previously with preliminary materials
¨ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
Your Vote
D
ep5e0i7p
5 Feb 24
Exempt offering of security
5:00pm
424B5
dbpkot
30 Jan 24
Prospectus supplement for primary offering
5:10pm
8-K
EX-10.1
bkhdp1il pnhd3i
30 Jan 24
Checkpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-Market
5:00pm
8-K
EX-10.1
i19uyr619p04pbp
31 Jul 23
Checkpoint Therapeutics Announces $10 Million Registered Direct Offering Priced At-the-Market
8:28am
424B5
5uysl4ext4t8
31 Jul 23
Prospectus supplement for primary offering
8:23am
424B5
ygr403w
24 May 23
Prospectus supplement for primary offering
5:25pm
8-K
EX-10.1
knz4nmjy1igbaqynlr0s
24 May 23
Checkpoint Therapeutics Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
5:24pm
D
r519ff49orc3zc
14 Apr 23
Indefinite amount in options / securities to be acquired, 9 investors
5:00pm